AG0030EV

30516-87-1 | Thymidine, 3'-azido-3'-deoxy-

AG0030EV

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	30516-87-1
Catalog Number	AG0030EV(AGN-PC-0O8R5E)
Chemical Name	Thymidine, 3'-azido-3'-deoxy-
IUPAC Name	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
InChI	InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1
InChI Key	HBOMLICNUCNMMY-XLPZGREQSA-N
MDL Number	MFCD00006536
Molecular Formula	C10H13N5O4
Molecular Weight	267.2413
NSC Number	758185
RTECS Number	XP2072000
SMILES	O=C1NC(C(C)=CN1[C@@H]2O[C@H](CO)[C@@H](N=[N+]=[N-])C2)=O
UNII	4B9XT59T7S
Synonyms	3' Azido 2',3' Dideoxythymidine, 3' Azido 3' deoxythymidine, 3'-Azido-2',3'-Dideoxythymidine, 3'-Azido-3'-deoxythymidine, Antiviral AZT, Azidothymidine, AZT (Antiviral), AZT Antiviral, AZT, Antiviral, BW A509U, BWA 509U, BWA-509U, BWA509U, Retrovir, Zidovudine, zidovudine, Azidothymidine, 30516-87-1, 3'-Azido-3'-deoxythymidine, Retrovir, AZT, Zidovudinum, Compound S, Thymidine, 3'-azido-3'-deoxy-, ZIDOVUDINE [AZT], BW A509U, zidovudin, Zidovudinum [Latin], Zidovudina [Spanish], BWA509U, ZDV, 3'-Azido-2',3'-Dideoxythymidine, DRG-0004, UNII-4B9XT59T7S, 3'-Deoxy-3'-azidothymidine, CCRIS 105, Aztec, NSC 602670, BW-A509U, BW-A-509U, HSDB 6515, MFCD00006536, 3'-Azido-3'-deoxythymidine (AIDS), CHEMBL129, BW-A 509U, MLS000028548, 4B9XT59T7S, 1-((2R,4S,5S)-4-AZIDO-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE, 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, CHEBI:10110, HBOMLICNUCNMMY-XLPZGREQSA-N, 3′-Azido-3′-deoxythymidine, NCGC00023945-05, SMR000058351, Zidovudina, DSSTox_CID_127, 3-Azido-3-deoxythymidine, AZT Antiviral, AZT, Antiviral, 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)-5-methylpyrimidine-2,4-(1H,3H)-dione, DSSTox_RID_75386, AZT (Antiviral), DSSTox_GSID_20127, Apo-Zidovudine, Novo-Azt, Propolis+AZT, Retrovir(TM), AZT & Li & EPO, Retrovir (TN), Zidovudine EP III, Cpd S, BWA-509U, Intron A & AZT, Racemic Liposomal AZT, Liposomal AZT-SN-1, Liposomal AZT-SN-3, Zidovudine+PRO 140, Zidovudine [USAN:INN:BAN:JAN], PC-SOD+AZT, AZT & srCD4, AZT & rIFN.alpha.2, AZT & rsT4, rIFN-beta seron & AZT, AZT & EPO, AZT & GM-CSF, AZT & HPA, AZT & sCD4, AZT & SST, zudovidine, AZT & Li & GM-CSF, AZT+PRO 140, Met-SDF-1.beta. & AZT, AZT & Li & IL-1, AZT & Li & IL-6, AZT & IL-1, AZT & IL-2, AZT & IL-6, AZT & Interferon-.alpha.-2, AZT & Concanavalin A (ConA), AZT & Lymphoblastoid Interferon, AZT & PM-19, Met-SDF-1.beta. & Zidovudine, 4lhm, 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AZT), 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione [AZT], AZT & rsCD4 & rIFN.alpha.A, 3'-azido-3'-deoxythymidine, AZT, DS-4152 & AZT, 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione, 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione, AZT & Colony-stimulating factor 2, AZT & NP (from PHCA or HSA), ZVD, 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine, 3''-azido-thymidine, K7 [P Ti2 W10 O40], Zidovudine [USAN:USP:INN:BAN:JAN], Zidovudine & IFNL1, Zidovudine & IFNL2, Zidovudine & IFNL3, Zidovudine (Retrovir), Spectrum_001348, AZT & CD4(178)-PE 40, AZT & IFN.alpha., Zidovudine & IL-29, Zidovudine & IL-28A, Zidovudine & IL-28B, AC1L1TKL, AC1Q2OEK, AZT & Interleukin 29, Opera_ID_1602, Prestwick3_000333, Spectrum2_000927, Spectrum3_001507, Spectrum4_000332, Spectrum5_001101, 3'azido-3'deoxythymidine, 3'-Azido-3'-deoxythymidine & Erythropoietin, 3'-Azido-3'-deoxythymidine & Sho-Saiko-To, Azidothymidine; Zidovudine, Interferon AD + 3'-azido-3'-deoxythymidine, AZT & Interleukin 28A, AZT & Interleukin 28B, 3'-Azido-3'-deoxythymidine & Concanavalin A, 3'-Azido-3'-deoxythymidine & Interleukin-1, 3'-Azido-3'-deoxythymidine & Interleukin-2, 3'-Azido-3'-deoxythymidine & Interleukin-6, AZT TRANSPLACENTAL CARCINOGENESIS STUDY, 3'-azido3'-deoxythymidine, AZT & IFNL1, AZT & IFNL2, AZT & IFNL3, AZT & Interferon lambda-1, AZT & Interferon lambda-2, AZT & Interferon lambda-3, 3''-Deoxy-3-azidothymidine, BSPBio_000365, BSPBio_003153, KBioGR_000703, KBioSS_001828, microthornmicro feminineEthOUO, MLS001055351, MLS001076358, MLS002153202, MLS002222249, Zidovudine & Interleukin 29, DivK1c_000524, SPECTRUM1502109, 3'-deoxy-3'-azido-thymidine, SPBio_000834, Zidovudine & Interleukin 28A, Zidovudine & Interleukin 28B, AZT & IL-28A, AZT & IL-28B, BPBio1_000403, GTPL4825, Zidovudine (JP17/USP/INN), 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin, 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1, 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6, 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon, DTXSID8020127, SCHEMBL14615088, SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle), SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle), AZT & IL-29, CTK4I2082, HMS501K06, KBio1_000524, KBio2_001828, KBio2_004396, KBio2_006964, KBio3_002653, KS-00000WOF, 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19, racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle), 3''-Azido-3''-deoxy-thymidine, NINDS_000524, Zidovudine & Interferon lambda-1, Zidovudine & Interferon lambda-2, Zidovudine & Interferon lambda-3, HMS1921J20, HMS2090G11, HMS2092D06, HMS2096C07, HMS2234K17, HMS3259H17, HMS3713C07, Pharmakon1600-01502109, 1-((2R,4R,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, ZINC3779042, 3''azido-2''3''-dideoxythymidine, Tox21_110062, Tox21_110894, Tox21_202203, Tox21_300578, AEe paragraph signa.o paragraph sign, ANW-26899, BBL033764, BDBM50002692, CCG-39924, CZ0012, NSC758185, STK801891, AKOS005622576, AKOS015842610, Tox21_110062_1, 3''-azido-2'',3''-dideoxythymidine, DB00495, LS-1159, MCULE-8664408343, NC00666, NSC-758185, IDI1_000524, NCGC00014918-01, NCGC00023945-03, NCGC00023945-04, NCGC00023945-06, NCGC00023945-07, NCGC00023945-08, NCGC00023945-09, NCGC00023945-10, NCGC00023945-12, NCGC00023945-13, NCGC00178237-01, NCGC00178237-02, NCGC00254276-01, NCGC00259752-01, 1-((2R,4S,5S)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 399024-19-2, AS-13019, CPD000058351, SAM002548971, SBI-0051731.P002, AB0012841, FT-0601543, Propolis & Thymidine, 3'-azido-3'-deoxy-, S2579, SW198799-2, EN300-52518, 3'-Azido-3'-deoxythymidine, >=98% (HPLC), C07210, D00413, J10271, W-5037, 3'-Azido-3'deoxythymidine & Interferon .alpha., 3'-Azido-3'-deoxythymidine, >=99.0% (HPLC), SR-01000000098, SR-05000001587, J-700147, SR-01000000098-3, SR-05000001587-1, BRD-K72903603-001-04-6, BRD-K72903603-001-14-5, Z1723414428, Zidovudine, European Pharmacopoeia (EP) Reference Standard, 3'-Azido-3'-deoxythymidine & Recombinant Interferon-.alpha.-2, Zidovudine, United States Pharmacopeia (USP) Reference Standard, 3'-Azido-3'-deoxythymidine & CD4-Pseudomonas exotoxin A hybrid, Beta interferon(rIFN-beta seron) & 3'-Azido-3'-deoxythymidine(AZT), Lecithinized superoxide dismutase & Thymidine, 3'-azido-3'-deoxy-, 3'-Azido-2',3'-dideoxythymidine & sCD4(soluble recombinant protein), Sulfated polysaccharide-peptidoglycan DS-4152 & 3'-Azido-3'-deoxythymidine, Thymidine, 3'-azido-3'-deoxy- & PRO 140 (Anti-CCR5 monoclonal antibody), Zidovudine, Pharmaceutical Secondary Standard; Certified Reference Material, (AZT) 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, (AZT)1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(AZT), 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione, 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione, 3'-Azido-3'-deoxythymidine & Lithium & Granulocyte-macrophage colony-stimulating factor, 3'-Azido-3'deoxythymidine & Recombinant Soluble CD4 & Recombinant Interferon.alpha.A, 4-(4-Azido-5-hydroxy-tetrahydro-furan-2-yl)-5-methyl-3H-pyrazine-2,6-dione, Met-Stromal Cell-derived Factor-1.beta. (Human) & 3'-Azido-3'-deoxythymidine, 1-((2R,4S,5S)-4-(diazoamino)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 1-((2R,4S,5S)-4-azido-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 1-((2R,5S)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 1-((2S,4R,5R)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AzddThd, AZT), 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (N3ddThd), 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(3''-azido-2'',3''-dideoxythymidine), 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(azidothymidine, AZT), 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(Zidovudine, AZT), 146426-54-2, 3'-Azido-3'deoxythymidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate), 3-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)triaz-1-en-2-ium-1-ide, 3-Azido-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-D-erythro- pentofuranuronic acid, Trizivir, antiviral, Combivir, Antiviral AZT, Azitidin, Dendrigen, -deoxythymidine, azidodeoxythymidine, Mixture Name, 3'-Azidothymidine, 3&prime, -Azido-3&prime, Retrovis (TN), AZT & IFN-alpha, Azidothymidine (AZT), ZIDOVUDINE (AZT), 3' Azido 3' deoxythymidine, D01XYJ, D0UF5H, D0YX5A, BWA 509U, Antiviral, Shanghai Genomics, Zidovudine (JAN/USP/INN), C10H13N5O4, 3' Azido 2',3' Dideoxythymidine, CTCE-0422, Antiviral, Chemokine Therapeutics, Timidina, 3'-azido-3'-desoxi-, Zidovudine [USAN:BAN:INN:JAN], CID35370, NSC602670, C10-H13-N5-O4, ACN-029241, CS-O-02590, Flt3 ligand (viral infection) Shanghai, H032, CAS-30516-87-1, Immunostimulant (viral infection), Shanghai, A2052, 3'-Azido-3'deoxythymidine & Interferon-alpha, 3'-Azido-3'-deoxythymidine, 98% - 1G 1g, D015215, 1-[ -4-azido-5- oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione, 3'-Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor, 25526-94-7,

Complexity	484
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	3
Defined Bond Stereocenter Count	0
Exact Mass	267.097g/mol
Formal Charge	0
Heavy Atom Count	19
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	267.245g/mol
Monoisotopic Mass	267.097g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	93.2A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H351
Packing Group	Ⅲ
Precautionary statements	P281
UN Code	UN 2811

Certificate of Analysis

Lot Number